Your browser doesn't support javascript.
loading
Validation of a New Patient-Reported Outcome Measure of the Functional Impact of Essential Tremor on Activities of Daily Living.
Shih, Ludy C; Stevenson, Michael T; Bellows, Steven; Fasano, Alfonso; Kuo, Sheng-Han; Lyons, Kelly E; Moore, Henry; Shill, Holly A; Shukla, Aparna Wagle; Singer, Carlos; Elble, Rodger J.
Affiliation
  • Shih LC; Beth Israel Deaconess Medical Center, Department of Neurology, Boston, MA 02215, US.
  • Stevenson MT; Harvard Medical School, Boston, MA 02215, US.
  • Bellows S; Boston Medical Center, Department of Neurology, Boston, MA 02118, US.
  • Fasano A; Baylor College of Medicine, Department of Neurology, Houston, TX, US.
  • Kuo SH; Edmond J. Safra Program in Parkinson's Disease, Morton and Gloria Shulman Movement Disorders Clinic, Toronto Western Hospital, UHN, Toronto, Ontario, Canada.
  • Lyons KE; Division of Neurology, University of Toronto, Toronto, Ontario, Canada.
  • Moore H; Krembil Brain Institute, Toronto, Ontario, Canada.
  • Shill HA; Columbia University, Department of Neurology, New York, NY, US.
  • Shukla AW; University of Kansas Medical Center, Department of Neurology, US.
  • Singer C; University of Miami School of Medicine, Department of Neurology, Miami, FL, US.
  • Elble RJ; Barrow Neurological Institute, Phoenix, AZ, US.
Article in En | MEDLINE | ID: mdl-38765931
ABSTRACT

Background:

The Essential Tremor Rating Assessment Scale (TETRAS) is a popular scale for essential tremor (ET), but its activities of daily living (ADL) and performance (P) subscales are based on a structured interview and physical exam. No patient-reported outcome (PRO) scale for ET has been developed according to US regulatory guidelines.

Objective:

Develop and validate a TETRAS PRO subscale.

Methods:

Fourteen items, rated 0-4, were derived from TETRAS ADL and structured cognitive interviews of 18 ET patients. Convergent validity analyses of TETRAS PRO versus TETRAS ADL, TETRAS-P, and the Quality of Life in Essential Tremor Questionnaire (QUEST) were computed for 67 adults with ET or ET plus. Test-retest reliability was computed at intervals of 1 and 30 days. The influence of mood (Hospital Anxiety and Depression Scale, HADS) and coping behaviors (Essen Coping Questionnaire, ECQ) was examined with multiple linear regression.

Results:

TETRAS PRO was strongly correlated (r > 0.7) with TETRAS ADL, TETRAS-P, and QUEST and exhibited good to excellent reliability (Cronbach alpha 95%CI = 0.853-0.926; 30-day test-retest intraclass correlation 95%CI = 0.814-0.921). The 30-day estimate of minimum detectable change (MDC) was 6.6 (95%CI 5.2-8.0). TETRAS-P (rsemipartial = 0.607), HADS depression (rsemipartial = 0.384), and the coping strategy of information seeking and exchange of experiences (rsemipartial = 0.176) contributed statistically to TETRAS PRO in a multiple linear regression (R2 = 0.67).

Conclusions:

TETRAS PRO is a valid and reliable scale that is influenced strongly by tremor severity, moderately by mood (depression), and minimally by coping skills. The MDC for TETRAS PRO is probably sufficient to detect clinically important change.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Activities of Daily Living / Essential Tremor / Patient Reported Outcome Measures Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Tremor Other Hyperkinet Mov (N Y) Year: 2024 Document type: Article Affiliation country: United States Country of publication: United kingdom

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Activities of Daily Living / Essential Tremor / Patient Reported Outcome Measures Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Tremor Other Hyperkinet Mov (N Y) Year: 2024 Document type: Article Affiliation country: United States Country of publication: United kingdom